![Thomson Reuters](https://static.lse.co.uk/images/news-logos/thomson-reuters-news-logo.png)
European stocks log steepest one-day fall this year as banks extend slide
European banks log worst two-day selloff in a year
*Read moreEuropean banks log worst two-day selloff in a year
*Read moreFeb 23 (Reuters) - The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months.
Read moreFeb 16 (Reuters) - Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc's heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the illness at an upcoming trial.
Read moreFeb 16 (Reuters) - GSK Plc is expected to urge a California judge on Thursday to limit what expert testimony jurors can hear in the first trial over claims that the company's heartburn drug Zantac caused cancer.
Read moreSTOXX 600 ends up 0.9%
*Read moreSTOXX 600 up 0.3%, logs gains for second straight week
*Read moreSees "low single digit" percentage core EPS growth, FX adjusted
*Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at
EUROPEAN SHARES SEEN LOWER (0730 GMT)Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at
MIND THE GAP (0656 GMT)Read moreJan 30 (Reuters) - Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.
Read moreJan 30 (Reuters) - Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.
Read moreArbitration decision initially expected by end of 2022
*Read more